Syncom Formulations | Income Statement

Fiscal year is April-March. All values INR Millions.
2013
2014
2015
2016
2017
Sales/Revenue
1,117
1,471
1,677
1,790
1,795
Cost of Goods Sold (COGS) incl. D&A
930
1,197
1,374
1,530
1,501
Gross Income
187
274
303
260
293
SG&A Expense
142
182
212
173
209
EBIT
45
133
91
87
137
Non Operating Income/Expense
37
4
54
58
19
Interest Expense
4
5
3
1
3
Pretax Income
84
139
156
161
159
Income Tax
28
46
59
57
53
Consolidated Net Income
57
93
98
104
105
Net Income
57
93
98
104
105
Net Income After Extraordinaries
57
93
98
104
105
Net Income Available to Common
57
93
98
104
105
EPS (Basic)
0.07
0.17
0.13
0.13
0.14
Basic Shares Outstanding
781
559
781
781
781
EPS (Diluted)
0.07
0.17
0.12
0.13
0.13
Diluted Shares Outstanding
781
559
781
781
781
EBITDA
74
163
125
117
169
Other Operating Expense
-
42
-
-
54
Non-Operating Interest Income
7
7
15
17
6

About Syncom Formulations

View Profile
Address
207, Saket Nagar
Indore Madhya Pradesh 452018
India
Employees -
Website http://www.syncomformulations.com
Updated 09/14/2018
Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company operates through the following segments: Pharmaceutical Drugs and Formulations, Trading of Commodities, and Renting of Property. Its products include tablets, ointment, liquid oral, capsules, and injections.